Assays to Identify Human CNVs

Applied Biosystems has developed TaqMan® Copy Number Assays for researchers to study the significant role that copy number variation (CNV) plays in human health and disease. The new line of genotyping assays have been designed to allow pharmaceutical, clinical and academic researchers to accurately detect CNVs from DNA samples, using real-time PCR.

The TaqMan Copy Number Assay solution consists of more than 1.6 million pre-designed TaqMan Copy Number Assays, and Custom TaqMan Copy Number Assays that allow researchers to detect CNVs if the assay for a specific gene or genomic region is not available in the pre-designed set. These solutions, in addition to data analysis software, are available on the Applied Biosystems website.

The TaqMan Copy Number Assays will help researchers to understand a host of biological processes including the development of cancer, immune system and neurological disorders, as well as how individuals respond to treatments for disease.